The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Balance of respective lines of stock

7 Aug 2013 09:29

RNS Number : 1508L
MyCelx Technologies Corporation
07 August 2013
 



7 August 2013

 

MYCELX TECHNOLOGIES CORPORATION

 

("MyCelx" or the "Company")

 

(AIM: MYX)

 

Balance of respective lines of stock

MyCelx confirms that the current balance of each line of stock, being the restricted line of Common Shares (ISIN USU624551078) and the unrestricted line of Common Shares (ISIN US62847T2024) which are able to be traded as Depository Interests in CREST, is as follows:

Line

ISIN

Balance of shares

ORD $0.025 (Restricted)

USU624551078

8,269,317

COM USD0.025 (Unrestricted)

US62847T2024

4,892,321

Total shares in issue

-

13,161,638

 

For further information please contact:

 

MyCelx Technologies Corporation

Connie Mixon, CEO

Mark Clark, CFO

 

Tel: +1 888 306 6843

 

Numis Securities Limited

Corporate Finance

Stuart Skinner / Jamie Loughborough

Tel: +44 20 7260 1000

 

Corporate Broking

James Black / Ben Stoop

Tel: +44 20 7260 1000

 

Pelham Bell Pottinger

Mark Antelme / Nick Lambert

Tel: +44 20 7861 3232

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLIFFTTDIDIIV

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.